Tag: Lupus nephritis

1. A significantly greater proportion of patients in the voclosporin group achieved complete renal responses after 52 weeks compared to the placebo group. 2. The safety profile between the voclosporin group and placebo group were comparable with 21% of patients in both groups experiencing serious adverse events. Evidence Rating Level: 1 (Excellent) Study Rundown: Nearly...
1. A significantly greater proportion of patients in the voclosporin group achieved complete renal responses after 52 weeks compared to the placebo group. 2. The safety profile between the voclosporin group and placebo group were comparable with 21% of patients in both groups experiencing serious adverse events. Evidence Rating Level: 1...
1. For patients with Lupus nephritis end stage renal disease (LN ESRD), renal transplant reduced the risk of death by about 70%. 2. The risk reduction was driven primarily by decreased risk of death from cardiovascular disease and infection. Evidence Rating Level: 2 (Good) Study Rundown: Lupus nephritis (LN) is a common...